LifeStance Health (LFST) Other Operating Expenses (2020 - 2026)

LifeStance Health has disclosed Other Operating Expenses across 7 years of filings, most recently posting $280.9 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 18.54% year-over-year to $280.9 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 14.4% YoY), while the FY2025 annual figure was $1.0 billion, up 10.7% from the prior year.
• Other Operating Expenses improved to $280.9 million in Q1 2026, from $269.3 million in the prior quarter.
• Over the last five years, Other Operating Expenses for LFST reached as high as $280.9 million in Q1 2026 and fell as low as $164.6 million in Q1 2022.
• The 5-year median for Other Operating Expenses is $227.4 million (2024), against an average of $220.2 million.
• Annual changes were most pronounced in 2022 — Other Operating Expenses soared 47.79% — and 2025, when it climbed 3.79%.
• A 5-year view of Other Operating Expenses shows it stood at $185.6 million in 2022, then gained by 18.3% to $219.5 million in 2023, then advanced by 5.11% to $230.7 million in 2024, then grew by 16.74% to $269.3 million in 2025, then grew by 4.28% to $280.9 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $280.9 million, $269.3 million, and $260.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.